SNDA · Sonida Senior Living, Inc. · Insider Trading

The reduction in shares set forth herein does not reflect a sale of these securities, but rather the termination of a non-discretionary investment advisory relationship between Conversant Capital LLC ("Conversant Capital") and a former limited partner of CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF"), which former limited partner previously received a distribution of shares of Common Stock in connection with its withdrawal from CPIF SAF. As a result of the termination of that advisory relationship, Conversant Capital and Michael Simanovsky (together, the "Reporting Persons") have ceased to have any interest in shares of Common Stock that may be held by such former CPIF SAF limited partner.

Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $38.00 to $38.79. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The changes in beneficial ownership reported hereby are a result of various sales made by a third-party seller that was previously a limited partner of CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF"), and received a distribution of shares of Common Stock in connection with its withdrawal from CPIF SAF. Conversant Capital LLC ("Conversant Capital") has a non-discretionary investment advisory relationship with, and an ongoing interest in the proceeds of the sale of shares of Common Stock by the third-party seller of these shares of Common Stock. By virtue of this advisory relationship and the relationship of Mr. Simanovsky and Conversant Capital, each of Conversant Capital and Mr. Simanovsky may be deemed a beneficial owner of such shares of Common Stock, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein. Mr. Simanovsky and Conversant Capital are referred to as the "Reporting Persons" within this statement.

Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $38.01 to $39.00. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The changes in beneficial ownership reported hereby are a result of various sales made by a third-party seller that was previously a limited partner of CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF"), and received a distribution of shares of Common Stock in connection with its withdrawal from CPIF SAF. Conversant Capital LLC ("Conversant Capital") has a non-discretionary investment advisory relationship with, and an ongoing interest in the proceeds of the sale of shares of Common Stock by the third-party seller of these shares of Common Stock. By virtue of this advisory relationship and the relationship of Mr. Simanovsky and Conversant Capital, each of Conversant Capital and Mr. Simanovsky may be deemed a beneficial owner of such shares of Common Stock, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein. Mr. Simanovsky and Conversant Capital are referred to as the "Reporting Persons" within this statement.

Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $39.09 to $39.31. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The changes in beneficial ownership reported hereby are a result of various sales made by a third-party seller that was previously a limited partner of CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF"), and received a distribution of shares of Common Stock in connection with its withdrawal from CPIF SAF. Conversant Capital LLC ("Conversant Capital") has a non-discretionary investment advisory relationship with, and an ongoing interest in the proceeds of the sale of shares of Common Stock by the third-party seller of these shares of Common Stock. By virtue of this advisory relationship and the relationship of Mr. Simanovsky and Conversant Capital, each of Conversant Capital and Mr. Simanovsky may be deemed a beneficial owner of such shares of Common Stock, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein. Mr. Simanovsky and Conversant Capital are referred to as the "Reporting Persons" within this statement.

The changes in beneficial ownership reported hereby are a result of various sales made by a third-party seller that was previously a limited partner of CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF"), and received a distribution of shares of Common Stock in connection with its withdrawal from CPIF SAF. Conversant Capital LLC ("Conversant Capital") has a non-discretionary investment advisory relationship with, and an ongoing interest in the proceeds of the sale of shares of Common Stock by the third-party seller of these shares of Common Stock. By virtue of this advisory relationship and the relationship of Mr. Simanovsky and Conversant Capital, each of Conversant Capital and Mr. Simanovsky may be deemed a beneficial owner of such shares of Common Stock, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein. Mr. Simanovsky and Conversant Capital are referred to as the "Reporting Persons" within this statement.

Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $40.50 to $41.40. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The changes in beneficial ownership reported hereby are a result of various sales made by a third-party seller that was previously a limited partner of CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF"), and received a distribution of shares of Common Stock in connection with its withdrawal from CPIF SAF. Conversant Capital LLC ("Conversant Capital") has a non-discretionary investment advisory relationship with, and an ongoing interest in the proceeds of the sale of shares of Common Stock by the third-party seller of these shares of Common Stock. By virtue of this advisory relationship and the relationship of Mr. Simanovsky and Conversant Capital, each of Conversant Capital and Mr. Simanovsky may be deemed a beneficial owner of such shares of Common Stock, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein. Mr. Simanovsky and Conversant Capital are referred to as the "Reporting Persons" within this statement.

Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $40.50 to $41.00. The Reporting Persons (as defined below) hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The changes in beneficial ownership reported hereby are a result of various sales made by a third-party seller that was previously a limited partner of CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF"), and received a distribution of shares of Common Stock in connection with its withdrawal from CPIF SAF. Conversant Capital LLC ("Conversant Capital") has a non-discretionary investment advisory relationship with, and an ongoing interest in the proceeds of the sale of shares of Common Stock by the third-party seller of these shares of Common Stock. By virtue of this advisory relationship and the relationship of Mr. Simanovsky and Conversant Capital, each of Conversant Capital and Mr. Simanovsky may be deemed a beneficial owner of such shares of Common Stock, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein. Mr. Simanovsky and Conversant Capital are referred to as the "Reporting Persons" within this statement.

On August 21, 2026, at the request of certain CPIF Sparti SAF, LP, a Delaware limited partnership ("CPIF SAF") limited partners unaffiliated with the Reporting Persons, and in satisfaction of pre-existing obligations of Conversant Private GP LLC, a Delaware limited liability company ("Conversant Private GP"), to such limited partners, Conversant Private GP caused CPIF SAF to distribute in kind an aggregate 1,182,595 shares of Common Stock to such limited partners for no consideration in connection with their withdrawal from CPIF SAF, including 369,447 shares of Common Stock of which each of Conversant Capital LLC ("Conversant Capital") and Michael Simanovsky may be deemed to remain a beneficial owner, as further described in footnote 11.

Securities are held by CPIF SAF.

Conversant Private GP is the general partner of CPIF K Co-Invest SPT A, L.P. ("CPIF K"), Conversant PIF Aggregator A LP, a Delaware limited partnership ("Aggregator A") and CPIF SAF. Conversant Capital is the investment manager to each of Aggregator A, CPIF K and CPIF SAF. Mr. Simanovsky is the managing member of Conversant Capital and Conversant Private GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital, and Conversant Private GP may be deemed a beneficial owner of these securities, but each disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein. Mr. Simanovsky, Conversant Capital, Conversant Private GP and CPIF SAF are referred to as the "Reporting Persons" within this statement.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

There is no expiration date for the right of the holder of Series B Convertible Preferred Stock to convert.

Securities are held by Investor A.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

There is no expiration date for the right of the holder of Series B Convertible Preferred Stock to convert.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

Securities are held by Investor B.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

Securities are held by Investor A.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

Securities are held by Investor B.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

Securities are held by Investor B.

There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

This Form 4 is being filed jointly by Michael Simanovsky, a United States citizen; Conversant Capital LLC, a Delaware limited liability company ("Conversant Capital"); Conversant GP Holdings LLC, a Delaware limited liability company ("Conversant GP"); Conversant Dallas Parkway (A) LP, a Delaware limited partnership ("Investor A"); and Conversant Dallas Parkway (B) LP, a Delaware limited partnership ("Investor B") (collectively the filing persons are the "Reporting Persons").

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

Securities are held by Investor B.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.

Securities are held by Investor A.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

Securities are held by Investor B.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

There is no expiration date for the right of the holder of Series B Convertible Preferred Stock to convert.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

Securities are held by Investor B.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.

Securities are held by Investor A.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

This Form 4 is being filed jointly by Michael Simanovsky, a United States citizen; Conversant Capital LLC, a Delaware limited liability company ("Conversant Capital"); Conversant GP Holdings LLC, a Delaware limited liability company ("Conversant GP"); Conversant Dallas Parkway (A) LP, a Delaware limited partnership ("Investor A"); and Conversant Dallas Parkway (B) LP, a Delaware limited partnership ("Investor B") (collectively the filing persons are the "Reporting Persons").

Securities are held by Investor A.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

There is no expiration date for the right of the holder of Series B Convertible Preferred Stock to convert.

Securities are held by Investor A.

Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on July 1, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.

Not included in this amount are 18,177 performance-based restricted stock units ("PSUs"), which are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Represents an award of PSUs representing a contingent right to receive one share of common stock, par value $0.01 per share ("Common Stock"), of the Issuer per PSU. Between 33% and 100% of the target number of PSUs granted, which were granted under the Sonida Senior Living, Inc. 2019 Omnibus Stock and Incentive Plan, as amended (the "2019 Plan"), are eligible to vest during a three-year period beginning on February 23, 2027 and ending on February 23, 2030 (the "Performance Period"), subject to a potential 30-day extension as set forth in the award agreement, based on the Issuer's Common Stock achieving specified prices per share during the Performance Period.

Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.

Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.

Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.

Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.

Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.

Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

Not included in this amount are (i) 11,692 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2027 and (ii) 12,723 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2028. Vesting for these awards is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

Not included in this amount are (i) 23,384 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2027 and (ii) 34,535 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

Not included in this amount are 4,252 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2027 and (ii) 5,453 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

This Amendment is filed solely to correct an administrative error in the original Form 4 filed on May 21, 2026. The original filing inadvertently reported the incorrect number of shares withheld for taxes, and this amendment corrects it to reflect the correct number of shares withheld for taxes. All other information remains accurate.

Not included in this amount are (i) 11,692 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2027 and (ii) 12,723 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2028. Vesting for these awards is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

Not included in this amount are (i) 5,315 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2027 and (ii) 7,271 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

Not included in this amount are (i) 14,881 performance-based RSUs that are eligible to vest from 0% to 150% following the end of 2027 and (ii) 19,085 performance-based RSUs that are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.

Not included in this amount are (i) 11,692 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2027 and (ii) 12,723 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.

Not included in this amount are (i) 23,384 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2027 and (ii) 34,535 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.

Not included in this amount are (i) 14,881 performance-based RSUs that are eligible to vest from 0% to 150% following the end of 2027 and (ii) 19,085 performance-based RSUs that are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.

Not included in this amount are (i) 5,315 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2027 and (ii) 7,271 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.

Not included in this amount are 4,252 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2027 and (ii) 5,453 performance-based RSUs which are eligible to vest from 0% to 150% following the end of 2028. Vesting for the award is subject to the Issuer's achievement of certain financial goals and certification by the Compensation Committee.

Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

This Form 4/A amends and restates the March 13, 2026 Form 4 filed jointly by Michael Simanovsky, a United States citizen; Conversant Capital LLC, a Delaware limited liability company ("Conversant Capital"); Conversant GP Holdings LLC, a Delaware limited liability company ("Conversant GP"); Conversant Dallas Parkway (A) LP, a Delaware limited partnership ("Investor A"); Conversant Dallas Parkway (B) LP, a Delaware limited partnership ("Investor B"); Conversant Private GP LLC, a Delaware limited liability company ("Conversant Private GP") and Conversant PIF Aggregator A LP, a Delaware limited partnership("Aggregator A") (collectively the "Reporting Persons"). The entries indicated by this footnote 1 have been amended, including to indicate that, pursuant to Rule 16b-3, all of the transactions reported herein are exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended.

Conversant Private GP is the general partner of Aggregator A, CPIF K Co-Invest SPT A, L.P., a Cayman Islands exempted limited partnership ("CPIF K") and CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF") and Conversant Capital is the investment manager to Aggregator A, CPIF K and CPIF SAF. Mr. Simanovsky is the managing member of Conversant Capital and Conversant Private GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant Private GP may be deemed a beneficial owner of the securities held by Aggregator A, CPIF K and CPIF SAF. Each of Mr. Simanovsky, Conversant Capital and Conversant Private GP disclaims beneficial ownership of the securities held by Aggregator A, CPIF K and CPIF SAF except to the extent of his or its pecuniary interest therein.

Securities are held by CPIF K.

Securities are held by Investor A.

Conversant GP is the general partner of each of Investor A, Investor B, Conversant Dallas Parkway (D) LP, a Delaware limited partnership ("Investor D") and Conversant Dallas Parkway (F) LP, a Delaware limited partnership ("Investor F"). Conversant Capital is the investment manager to each of Investor A, Investor B, Investor D and Investor F. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A, Investor B, Investor D and Investor F. Each of Mr. Simanovsky, Conversant Capital, and Conversant GP disclaims beneficial ownership of the securities held by Investor A, Investor B, Investor D and Investor F except to the extent of his or its pecuniary interest therein.

On March 11, 2026, the Issuer agreed with each of Investor A and Investor B to (i) amend the shares of Series A Convertible Preferred Stock to reduce the conversion price to $32 per share of Common Stock, (ii) make a onetime payment of approximately $5.8 million in the aggregate, which included approximately $1.1 million of accrued but unpaid dividends for the period of January 1, 2026 through March 11, 2026, to Investor A and Investor B pro rata in accordance with their holdings of Series A Convertible Preferred Stock, and (iii) extend the expiration of the Warrants by one year, from November 3, 2026 to November 3, 2027, and each of Investor A and Investor B agreed to immediately thereafter convert its shares of Series A Convertible Preferred Stock to shares of Common Stock.

Conversant GP is the general partner of each of Investor A, Investor B, Conversant Dallas Parkway (D) LP, a Delaware limited partnership ("Investor D") and Conversant Dallas Parkway (F) LP, a Delaware limited partnership ("Investor F"). Conversant Capital is the investment manager to each of Investor A, Investor B, Investor D and Investor F. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A, Investor B, Investor D and Investor F. Each of Mr. Simanovsky, Conversant Capital, and Conversant GP disclaims beneficial ownership of the securities held by Investor A, Investor B, Investor D and Investor F except to the extent of his or its pecuniary interest therein.

Securities are held by Investor B.

This Form 4/A amends and restates the March 13, 2026 Form 4 filed jointly by Michael Simanovsky, a United States citizen; Conversant Capital LLC, a Delaware limited liability company ("Conversant Capital"); Conversant GP Holdings LLC, a Delaware limited liability company ("Conversant GP"); Conversant Dallas Parkway (A) LP, a Delaware limited partnership ("Investor A"); Conversant Dallas Parkway (B) LP, a Delaware limited partnership ("Investor B"); Conversant Private GP LLC, a Delaware limited liability company ("Conversant Private GP") and Conversant PIF Aggregator A LP, a Delaware limited partnership("Aggregator A") (collectively the "Reporting Persons"). The entries indicated by this footnote 1 have been amended, including to indicate that, pursuant to Rule 16b-3, all of the transactions reported herein are exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended.

On March 11, 2026, the Issuer agreed with each of Investor A and Investor B to (i) amend the shares of Series A Convertible Preferred Stock to reduce the conversion price to $32 per share of Common Stock, (ii) make a onetime payment of approximately $5.8 million in the aggregate, which included approximately $1.1 million of accrued but unpaid dividends for the period of January 1, 2026 through March 11, 2026, to Investor A and Investor B pro rata in accordance with their holdings of Series A Convertible Preferred Stock, and (iii) extend the expiration of the Warrants by one year, from November 3, 2026 to November 3, 2027, and each of Investor A and Investor B agreed to immediately thereafter convert its shares of Series A Convertible Preferred Stock to shares of Common Stock.

There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.

Securities are held by Investor A.

Conversant GP is the general partner of each of Investor A, Investor B, Conversant Dallas Parkway (D) LP, a Delaware limited partnership ("Investor D") and Conversant Dallas Parkway (F) LP, a Delaware limited partnership ("Investor F"). Conversant Capital is the investment manager to each of Investor A, Investor B, Investor D and Investor F. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A, Investor B, Investor D and Investor F. Each of Mr. Simanovsky, Conversant Capital, and Conversant GP disclaims beneficial ownership of the securities held by Investor A, Investor B, Investor D and Investor F except to the extent of his or its pecuniary interest therein.

This Form 4/A amends and restates the March 13, 2026 Form 4 filed jointly by Michael Simanovsky, a United States citizen; Conversant Capital LLC, a Delaware limited liability company ("Conversant Capital"); Conversant GP Holdings LLC, a Delaware limited liability company ("Conversant GP"); Conversant Dallas Parkway (A) LP, a Delaware limited partnership ("Investor A"); Conversant Dallas Parkway (B) LP, a Delaware limited partnership ("Investor B"); Conversant Private GP LLC, a Delaware limited liability company ("Conversant Private GP") and Conversant PIF Aggregator A LP, a Delaware limited partnership("Aggregator A") (collectively the "Reporting Persons"). The entries indicated by this footnote 1 have been amended, including to indicate that, pursuant to Rule 16b-3, all of the transactions reported herein are exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended.

On March 11, 2026, the Issuer agreed with each of Investor A and Investor B to (i) amend the shares of Series A Convertible Preferred Stock to reduce the conversion price to $32 per share of Common Stock, (ii) make a onetime payment of approximately $5.8 million in the aggregate, which included approximately $1.1 million of accrued but unpaid dividends for the period of January 1, 2026 through March 11, 2026, to Investor A and Investor B pro rata in accordance with their holdings of Series A Convertible Preferred Stock, and (iii) extend the expiration of the Warrants by one year, from November 3, 2026 to November 3, 2027, and each of Investor A and Investor B agreed to immediately thereafter convert its shares of Series A Convertible Preferred Stock to shares of Common Stock.

Securities are held by Investor A.

Conversant GP is the general partner of each of Investor A, Investor B, Conversant Dallas Parkway (D) LP, a Delaware limited partnership ("Investor D") and Conversant Dallas Parkway (F) LP, a Delaware limited partnership ("Investor F"). Conversant Capital is the investment manager to each of Investor A, Investor B, Investor D and Investor F. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A, Investor B, Investor D and Investor F. Each of Mr. Simanovsky, Conversant Capital, and Conversant GP disclaims beneficial ownership of the securities held by Investor A, Investor B, Investor D and Investor F except to the extent of his or its pecuniary interest therein.